News Releases
- Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron (Statistically Significant Efficacy and a Safety Profile Consistent with Injectable GLP-1 Medicines in Phase III ACHIEVE-1 for Type 2 Diabetes)
- First Positive Phase III Results Presented at Japanese Ophthalmological Society Meeting Demonstrated that Vabysmo Sufficiently Improved Vision in Japanese Patients with Angioid Streaks
- Roche’s Announcement Regarding Trontinemab (Presentation of Latest Data in Alzheimer’s Disease at AD/PD)
Science and Technology
Science and Technology
Careers at Chugai
Careers at Chugai
Videos
CPR celebrates 10th Anniversary